PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+34.82%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$11.6B
AUM Growth
+$2.27B
(+24%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
350
New
64
Increased
74
Reduced
125
Closed
73
Top Buys
| 1 |
PayPal
PYPL
|
$133M |
| 2 |
Meta Platforms (Facebook)
META
|
$115M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
$110M |
| 4 |
UnitedHealth
UNH
|
$110M |
| 5 |
Ciena
CIEN
|
$94M |
Top Sells
| 1 |
AbbVie
ABBV
|
$85.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$83.2M |
| 3 |
Amazon
AMZN
|
$83M |
| 4 |
Intel
INTC
|
$72.3M |
| 5 |
RingCentral
RNG
|
$71.8M |
Sector Composition
| 1 | Technology | 36.18% |
| 2 | Healthcare | 19.13% |
| 3 | Financials | 17.17% |
| 4 | Communication Services | 12.96% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Analog Devices
ADI
$120B
| $29.9M | 0.26% |
243,582
-162,605
| -40% | -$19.9M |
|
|
ALXN
102
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $29.7M | 0.26% |
265,000
-80,934
| -23% | -$9.08M |
|
103
Envista
NVST
$3.37B
| $29.5M | 0.25% |
1,397,625
-352,555
| -20% | -$7.44M |
|
104
Ametek
AME
$42.6B
| $28.3M | 0.24% |
316,656
-109,872
| -26% | -$9.82M |
|
105
Elevance Health
ELV
$72.4B
| $27.9M | 0.24% |
106,110
-100,353
| -49% | -$26.4M |
|
106
Teleflex
TFX
$5.57B
| $27.7M | 0.24% |
+76,130
| New | +$27.7M |
|
107
Agilent Technologies
A
$35.5B
| $27.7M | 0.24% |
313,414
-283,044
| -47% | -$25M |
|
108
Addus HomeCare
ADUS
$2.08B
| $27.2M | 0.23% |
293,488
+60,485
| +26% | +$5.6M |
|
109
Pinterest
PINS
$25.2B
| $26.9M | 0.23% |
1,211,618
-2,576,163
| -68% | -$57.1M |
|
110
Icon
ICLR
$14B
| $25.8M | 0.22% |
152,871
-84,354
| -36% | -$14.2M |
|
111
James River Group
JRVR
$256M
| $24.8M | 0.21% |
550,000
| – | – |
|
112
Tactile Systems Technology
TCMD
$295M
| $24.7M | 0.21% |
595,642
+392,043
| +193% | +$16.2M |
|
113
US Foods
USFD
$17.4B
| $24.3M | 0.21% |
1,232,028
-206,692
| -14% | -$4.08M |
|
|
AVDL
114
Avadel Pharmaceuticals
AVDL
$1.45B
| $24.1M | 0.21% |
+2,978,915
| New | +$24.1M |
|
115
First American
FAF
$6.63B
| $22.8M | 0.2% |
475,000
+40,000
| +9% | +$1.92M |
|
116
Dolby
DLB
$6.94B
| $22.6M | 0.2% |
343,265
-208,468
| -38% | -$13.7M |
|
117
SS&C Technologies
SSNC
$21.3B
| $22.6M | 0.19% |
399,468
-169,374
| -30% | -$9.57M |
|
118
Johnson & Johnson
JNJ
$429B
| $22.4M | 0.19% |
159,352
-92,951
| -37% | -$13.1M |
|
119
Altria Group
MO
$112B
| $22.4M | 0.19% |
570,813
-149,580
| -21% | -$5.87M |
|
120
Enovis
ENOV
$1.75B
| $22.3M | 0.19% |
463,948
-81,659
| -15% | -$3.92M |
|
121
RLI Corp
RLI
$6.17B
| $22M | 0.19% |
535,000
-48,000
| -8% | -$1.97M |
|
122
Y-mAbs Therapeutics
YMAB
$390M
| $21.9M | 0.19% |
506,083
+125,000
| +33% | +$5.4M |
|
123
Intercontinental Exchange
ICE
$100B
| $21.4M | 0.18% |
233,824
-35,998
| -13% | -$3.3M |
|
124
Citigroup
C
$175B
| $21M | 0.18% |
411,094
-50,924
| -11% | -$2.6M |
|
125
Merck
MRK
$210B
| $20.9M | 0.18% |
282,722
-440,891
| -61% | -$32.5M |
|